What's Happening?
A recent review published in the Journal of Cellular and Molecular Medicine highlights the increasing prevalence of antibiotic resistance genes in oral microbes, particularly in individuals with gum disease. The review, which synthesizes decades of evidence
on antimicrobial resistance in periodontal disease, concludes that current empirical antibiotic prescribing practices in dentistry are accelerating this problem. Dentists are responsible for approximately 10% of antibiotic prescriptions globally, contributing significantly to the development of resistance. The study notes a concerning trend in the U.S., with a 20-year surveillance of 2,193 periodontitis patients showing a fivefold increase in clindamycin-resistant P. gingivalis and a 28-fold increase in amoxicillin resistance between 2019 and 2020 compared to 1999-2000. The review advocates for a fundamental shift towards precision prescribing, based on mapping the full collection of resistance genes in the mouth, known as the periodontal resistome.
Why It's Important?
The widespread presence of antibiotic resistance genes in oral microbes poses a significant public health threat, extending beyond dental health. Oral bacteria can translocate to other body sites via the bloodstream, broadening the ecological impact of oral resistomes and potentially contributing to systemic infections that are harder to treat. The current empirical approach to antibiotic prescribing in dentistry, where antibiotics are chosen based on clinical judgment rather than specific pathogen identification and susceptibility testing, is exacerbating the problem. This practice not only reduces the effectiveness of treatments for periodontitis, which affects over a billion people globally, but also contributes to the broader crisis of antimicrobial resistance. The economic burden of drug-resistant infections is substantial, leading to longer hospital stays, more complications, and increased healthcare resource utilization. Without a shift to precision medicine, the U.S. healthcare system could face escalating costs and reduced efficacy in treating common bacterial infections.
What's Next?
The review calls for significant scientific and methodological advancements to make precision periodontal therapy routine. This includes integrating open-ended, high-resolution tools like shotgun metagenomics to map resistance genes, mobile genetic elements, and gene transfer networks. Standardization of sampling and testing methods, along with resistome-phenotype correlation studies and consensus definitions of clinically meaningful resistance, are also crucial next steps. The development of point-of-care molecular assays could eventually support targeted prescribing and reduce unnecessary antibiotic exposure, though these technologies are currently largely confined to research settings due to cost and complexity. Comprehensive periodontal resistome mapping across diverse populations and health states will be central to transitioning from empirical antibiotic use to precision-based, stewardship-aligned periodontal care, aiming to preserve the effectiveness of existing antibiotics.
Beyond the Headlines
The findings underscore a critical ethical and public health dilemma: the balance between immediate patient care and the long-term societal impact of antibiotic overuse. The review highlights that even subinhibitory antibiotic concentrations can select for resistant phenotypes, suggesting that the problem is not solely about over-prescription but also about the manner and duration of antibiotic use. The concept of the 'oral resistome' as a significant reservoir of resistance genes emphasizes the interconnectedness of microbial ecosystems within the body and their role in the broader antimicrobial resistance crisis. This necessitates a holistic approach to health, recognizing that dental practices have far-reaching implications for overall public health and the global fight against superbugs. The shift towards precision dentistry could serve as a model for other medical fields grappling with antibiotic resistance, promoting more responsible and effective antimicrobial stewardship.
